These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

639 related articles for article (PubMed ID: 3128869)

  • 1. Interferon-gamma: the major mediator of resistance against Toxoplasma gondii.
    Suzuki Y; Orellana MA; Schreiber RD; Remington JS
    Science; 1988 Apr; 240(4851):516-8. PubMed ID: 3128869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD8+ T lymphocytes are the major cell population involved in the early gamma interferon response and resistance to acute primary Toxoplasma gondii infection in mice.
    Shirahata T; Yamashita T; Ohta C; Goto H; Nakane A
    Microbiol Immunol; 1994; 38(10):789-96. PubMed ID: 7869956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rudolf-Virchow Prize 1998. Award lecture. Toxoplasmosis: a model infection for studying systemic and intracerebral immune reactions].
    Deckert-Schlüter M
    Verh Dtsch Ges Pathol; 1998; 82():9-22. PubMed ID: 10095413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune responses associated with early survival after peroral infection with Toxoplasma gondii.
    McLeod R; Eisenhauer P; Mack D; Brown C; Filice G; Spitalny G
    J Immunol; 1989 May; 142(9):3247-55. PubMed ID: 2496163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of endogenous IFN-gamma for prevention of toxoplasmic encephalitis in mice.
    Suzuki Y; Conley FK; Remington JS
    J Immunol; 1989 Sep; 143(6):2045-50. PubMed ID: 2506275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased resistance of B cell-deficient mice to infection with Toxoplasma gondii despite unimpaired expression of IFN-gamma, TNF-alpha, and inducible nitric oxide synthase.
    Kang H; Remington JS; Suzuki Y
    J Immunol; 2000 Mar; 164(5):2629-34. PubMed ID: 10679102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effector cells of both nonhemopoietic and hemopoietic origin are required for interferon (IFN)-gamma- and tumor necrosis factor (TNF)-alpha-dependent host resistance to the intracellular pathogen, Toxoplasma gondii.
    Yap GS; Sher A
    J Exp Med; 1999 Apr; 189(7):1083-92. PubMed ID: 10190899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granule-dependent killing of Toxoplasma gondii by CD8+ T cells.
    Nakano Y; Hisaeda H; Sakai T; Zhang M; Maekawa Y; Zhang T; Nishitani M; Ishikawa H; Himeno K
    Immunology; 2001 Nov; 104(3):289-98. PubMed ID: 11722643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8+ T cells from mice vaccinated against Toxoplasma gondii are cytotoxic for parasite-infected or antigen-pulsed host cells.
    Hakim FT; Gazzinelli RT; Denkers E; Hieny S; Shearer GM; Sher A
    J Immunol; 1991 Oct; 147(7):2310-6. PubMed ID: 1918963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of CD4+ T cell-dependent, interferon-gamma-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii.
    Liesenfeld O; Kosek J; Remington JS; Suzuki Y
    J Exp Med; 1996 Aug; 184(2):597-607. PubMed ID: 8760813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to Toxoplasma gondii major surface protein (SAG-1, P30) inhibit infection of host cells and are produced in murine intestine after peroral infection.
    Mineo JR; McLeod R; Mack D; Smith J; Khan IA; Ely KH; Kasper LH
    J Immunol; 1993 May; 150(9):3951-64. PubMed ID: 7682587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depletion of CD4+ T cells but not inhibition of the protective activity of IFN-gamma prevents cure of toxoplasmosis mediated by drug therapy in mice.
    Araujo FG
    J Immunol; 1992 Nov; 149(9):3003-7. PubMed ID: 1357033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA immunization with eukaryotic initiation factor-2α of Toxoplasma gondii induces protective immunity against acute and chronic toxoplasmosis in mice.
    Chen J; Huang SY; Zhou DH; Li ZY; Petersen E; Song HQ; Zhu XQ
    Vaccine; 2013 Dec; 31(52):6225-31. PubMed ID: 24183979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of anti-IFN-gamma antibody on the protective effect of Lyt-2+ immune T cells against toxoplasmosis in mice.
    Suzuki Y; Remington JS
    J Immunol; 1990 Mar; 144(5):1954-6. PubMed ID: 2106557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor-independent protective effect of recombinant IFN-gamma against acute toxoplasmosis in T cell-deficient mice.
    Suzuki Y; Joh K; Kobayashi A
    J Immunol; 1991 Oct; 147(8):2728-33. PubMed ID: 1918987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heat shock protein 65 induced by gammadelta T cells prevents apoptosis of macrophages and contributes to host defense in mice infected with Toxoplasma gondii.
    Hisaeda H; Sakai T; Ishikawa H; Maekawa Y; Yasutomo K; Good RA; Himeno K
    J Immunol; 1997 Sep; 159(5):2375-81. PubMed ID: 9278328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma delta T cells play an important role in hsp65 expression and in acquiring protective immune responses against infection with Toxoplasma gondii.
    Hisaeda H; Nagasawa H; Maeda K; Maekawa Y; Ishikawa H; Ito Y; Good RA; Himeno K
    J Immunol; 1995 Jul; 155(1):244-51. PubMed ID: 7602101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-gamma receptor-deficiency renders mice highly susceptible to toxoplasmosis by decreased macrophage activation.
    Deckert-Schlüter M; Rang A; Weiner D; Huang S; Wiestler OD; Hof H; Schlüter D
    Lab Invest; 1996 Dec; 75(6):827-41. PubMed ID: 8973478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heat stress-induced modulation of host defense against Toxoplasma gondii infection in mice.
    Nishiya K; Norose K; Aosai F; Chen M; Mun HS; Kang HK; Miyazaki M; Yano A
    J Parasitol; 2005 Jun; 91(3):702-6. PubMed ID: 16108573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of STAT4-dependent and independent mechanisms of resistance to Toxoplasma gondii.
    Cai G; Radzanowski T; Villegas EN; Kastelein R; Hunter CA
    J Immunol; 2000 Sep; 165(5):2619-27. PubMed ID: 10946290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.